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Objectives
 Understand the use of Medication-Assisted Treatment (MAT), 
in combination with counseling and behavioral therapies, and 
access to a range of supportive services, such as housing and 
employment services, to assist the mother in achieving a more 
stable life.
 Understand the impact of opiate addiction on pregnant 
women and neonatal abstinence syndrome (NAS )diagnosis 
means as infant tests positive for drugs in our community.
 Understand the mission of the Substance Abuse Treatment 
Education and Prevention Program (STEPP)  and Stable Cradle 
programs. 
Background Information 
 Opioid use in pregnancy has escalated 
dramatically in recent years, paralleling the 
epidemic observed in the general population. 
 Rates of admission to substance use disorder 
treatment programs have more than 
quadrupled between 2002 and 2012 , and 
rates of death associated with opioids has 
increase by  400% between 2000 and 2014 . 
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Background Information 
 During pregnancy, chronic untreated addiction to 
heroin is associated with lack of prenatal care, 
increased risk of fetal growth restriction, abruptio 
placentae, fetal death, preterm labor, and 
intrauterine passage of meconium . 
 Untreated addiction is associated with engagement 
in high-risk activities, such as prostitution, trading sex 
for drugs, and criminal activities. 
 Such behaviors expose women to STIs, violence, and 
legal consequences, including loss of child custody, 
criminal proceedings, or incarceration.
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Background Information
 Pregnant women with opioid use disorder 
often suffer from co-occurring mental health 
conditions, particularly depression, history of 
trauma, posttraumatic stress disorder, and 
anxiety. 
 More than 30% of pregnant women enrolled in 
a substance use treatment program screened 
positive for moderate to severe depression, 
and more than 40% reported symptoms of 
postpartum depression
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Background Information
 Pregnant women with opioid disorders  often 
suffer from poor nutrition, and many have 
disrupted support systems leading to social 
service needs. 
 Identifying these problems during pregnancy 
with referral for specialized multidisciplinary 
care is important to achieve optimal care for 
these women
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-
in-Pregnancy
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Services  for Pregnant Women with Opioid 
Disorder 
 Limited Providers and Health care professionals 
certified to provide Medication Assisted Treatment 
(MAT).
 Outpatient comprehensive treatment with MAT for 
pregnant women offered at Amethyst, CompDrug, 
Maryhaven, Netcare Access, OhioGuidestone, STEPP 
Clinic at OSUWMC and OhioHealth 
 Maryhaven offers residential treatment programs for 
pregnant women with children and Amethyst offers 
supportive housing for women and children. 
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What We Know?
 Through early November 2017, ADAMH of 
Franklin County providers report treating 100 
pregnant or postpartum women. 
 In 2016, City of Columbus medics documented 
administering Narcan to 7 pregnant women 
and 2 children under age one. 
 Through August 2017, Narcan has been 
administered to 5 pregnant women and no 
children under age one. 
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What We Know??
In 2016, Franklin County Children Services reported 907 
(76%) of screened-in cases of child abuse or neglect 
mention opiate use. 
SAMHSA reports that  4.7 percent of women of child-
bearing age are addicted to opiates. This extrapolates 
to approximately 900 pregnant women with addiction 
in Franklin County who may be misusing opiates. 
From June 2016 through July 2017, Columbus Public 
Health reports 166 NAS infants were treated in 
hospitals, and were residents of  Franklin County. 
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What We Know??
• From 2015 through 2017, only one percent of Franklin 
County babies diagnosed with Neonatal Abstinence 
Syndrome (NAS), with a complete data history, were born 
less than 32 weeks gestational age. (Billable Medical Codes 
ICD9: 779.5; ICD10: P96.1) 
• 55-94 percent of babies born to women using opiates 
experience signs of withdrawal, usually within 72 hours of 
birth, although some experience symptoms later. (American 
Academy of Pediatrics) 
• However, data on long-term development outcomes related 
to NAS are limited. (American Academy of Pediatrics)
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Screening for Opioids 
 Screening for opioid use should take place 
during the first prenatal care visit using the 
appropriate validated clinical screening tools, 
such as questionnaires. 
 Verbal screening and urine testing for initial 
screening of opioid use.  
 Additionally, physicians should be aware of 
general and state required reporting mandates 
for opioid use.
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Questions to Identify Dependencey
 Do you feel like you need to use more of the drug/alcohol to get the 
same effect?
 Do you [feel ill (opioids)/have the “shakes” (alcohol)] when you don’t use 
[opioids/alcohol]? • Do you feel like you can’t just have one drink or end 
up using more opioids/ alcohol than you intended?
 Have you been unable to stop or reduce your drinking/opioid use when 
you have tried in the past?
 Are you spending more and more time getting opioids/alcohol, using 
opioids/alcohol, or recovering from opioids/alcohol use?
 Does your drinking/opioid use get in the way of you doing other things 
that don’t involve alcohol/opioids, like work or family activities?
 Have any bad things happened as a result of your drinking/opioid use? 
Do you continue to drink/use opioids even though it causes these bad 
things to happen?
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STEPP Clinic
Substance Abuse Treatment Education and Prevention Program
 Central Ohio’s oldest and most comprehensive 
treatment center for individuals pregnant 
dealing with addiction.
 More than 500 expectant mothers have 
received treatment for addiction disorders.
 The program uses harm elimination rather 
than harm elimination.
 Patients are treated either outpatients or at a 
residence program at Maryhaven’s Women 
program.
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Steps for Pregnant Women with Opioid 
Disorders
 Expanded sexually transmitted infection [STI] testing, 
additional ultrasound and examinations to assess fetal in 
order to meet the clinical needs of the patient’s particular 
situation. 
 Breastfeeding should be encouraged and if there is no other 
contraindications, such as human immunodeficiency virus 
(HIV) infection. 
 Adequate postpartum psychosocial support services, including 
substance use disorder treatment and relapse prevention 
programs.
 Contraceptive counseling and access to contraceptive services 
should be a routine part .
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-
in-Pregnancy
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Services for Pregnant Women 
 Access challenges arise with the need to combine 
prenatal care with addiction treatment. 
 Currently a limited number of Board-certified, 
addiction-medicine specialists and Medication-
Assisted Treatment (MAT)-certified physicians in 
Central Ohio who also provide prenatal care. 
 Depending upon economic indicators or 
neighborhood-of-residence, pregnant women with 
the disease of addiction may also be receiving social 
supports from a home-visiting program and/or 
Moms2B. 
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Medication-Assisted Treatment at STEPP
 Medication-Assisted Treatment (MAT) is available at 
the STEPP (Substance Abuse, Treatment, Education and 
Prevention Program) Clinic affiliated with the Ohio State 
University Wexner Medical Center, within the OhioHealth 
system, and at individual medical practices treating 
obstetric patients. 
 For many obstetric physicians, referrals must be made to 
other physicians certified to prescribe MAT. The number 
of patients that can be treated within prenatal care 
practices is limited. 
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Recommendation from ACOG
 The American College of Obstetricians and Gynecologists 
(ACOG) makes the following recommendations and 
conclusions:
1. For pregnant women with an opioid use disorder, 
opioid agonist pharmacotherapy is the recommended therapy 
and is preferable to medically supervised withdrawal. 
2. Infants born to women who used opioids during 
pregnancy should be monitored by a pediatric care provider for 
neonatal abstinence syndrome.
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-
Opioid-Use-Disorder-in-Pregnancy
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FDA Approved Medications 
 FDA approved medications, including extended-release, 
injectable naltrexone (Vivitrol®) for alcohol dependence 
and buprenorphine/naloxone (Suboxone®) for opioid 
dependence.
 The addition of these medications to a standard drug or 
alcohol counseling program or self-help program may 
improve outcomes over counseling or support alone.
https://www.integration.samhsa.gov/clinical-practice/mat/RAND_MAT_guidebook_for_health_centers.pdf
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Methadone
 Dispensed on a daily basis and should be part 
of comprehensive treatment, including 
addiction counseling, family therapy, 
nutritional education, and other medical and 
psychosocial services as indicated. 
 Maternal methadone dosages are managed 
within registered opioid treatment programs.
 Dosages should be titrated until  
asymptomatic.
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-
and-Opioid-Use-Disorder-in-Pregnancy
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Buprenorphine 
 Recent evidence supports the use of buprenorphine 
for opioid use disorder treatment during pregnancy.
 Advantages of buprenorphine over methadone 
include fewer drug interactions, the ability to be 
treated on an outpatient basis. In addition, several 
trials demonstrate evidence of less-severe neonatal 
abstinence syndrome 
 There is not a similar risk of withdrawal when 
transitioning from buprenorphine to methadone. 
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-
and-Opioid-Use-Disorder-in-Pregnancy
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Naloxone 
 Is a short-acting opioid antagonist that can 
rapidly reverse the effects of opioids and can 
be life-saving in the setting of opioid overdose. 
 Although induced withdrawal may possibly 
contribute to fetal stress, naloxone should be 
used in pregnant women in the case of 
maternal overdose in order to save the 
woman’s life.
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-
in-Pregnancy
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Opioid Use During pregnancy
 Complications affecting the unborn fetus and include 
fetal growth restriction, placental abruption, and 
even fetal death. Opiate withdrawal during pregnancy 
increases the risk of fetal distress, miscarriage, and 
premature labor. 
 According to the American College of Obstetricians 
and Gynecologists, chronic untreated opioid 
addiction during pregnancy increases the risk of 
pregnancy complications. 
 Additionally, women addicted to opioids tend to 
avoid medical settings during pregnancy. 
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Intrapartum Care
 Women taking methadone or buprenorphine in labor should have their maintenance dose continued and should receive additional pain relief. 
 Epidural or spinal anesthesia should be offered, when appropriate, for management of pain in labor or for delivery. 
 Patients taking methadone or buprenorphine requires higher doses of opioids to achieve analgesia because they are tolerant to their maintenance treatment dose. 
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-
Disorder-in-Pregnancy
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Postpartum 
 The postpartum period vulnerable time for 
new moms, in general, as they face the 
stresses of sleep deprivation, caring for a 
newborn, and possibly symptoms of 
postpartum depression. 
 Women with opioid use disorder are dealing 
with all those things in addition to the 
challenges of their addiction, which without 
treatment and support can often lead to 
relapse. 
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-
and-Opioid-Use-Disorder-in-Pregnancy
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After Care 
 Encourage breastfeeding in women who are stable on 
their treatment, who are not using illicit drugs and 
who have no other contraindications. 
 Breastfeeding  decreased severity of neonatal 
abstinence syndrome, shorter hospital stay, and less 
need for the baby to receive medication to treat their 
withdrawal symptoms. 
 Contraceptive options as the unintended pregnancy 
rate among this population—80 percent—far 
surpasses the national average.
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-
and-Opioid-Use-Disorder-in-Pregnancy
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Neonatal Abstinence Syndrome (NAS) 
 NAS means an infant tests positive for certain drugs 
and is treated by the health care system. (SAMHSA, 
Journal of the American Medical Association) 
 Characterized by disturbances in gastrointestinal, 
autonomic, and central nervous systems, leading to a 
range of symptoms including irritability, high-pitched 
cry, poor sleep, and uncoordinated sucking reflexes 
that lead to poor feeding. 
 In infants exposed to methadone, symptoms of 
withdrawal may begin anytime in the first 2 weeks of 
life, but usually appear within 72 hours of birth.
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Long-Term Infant Outcomes 
 A major challenge in assessing outcomes is isolating 
the effects of opioid agonists from use of other 
substances (tobacco, alcohol, nonmedical drugs) and 
exposure to environmental and other medical risk 
factors (low socioeconomic status, poor prenatal 
care).
 Studies have not found significant differences in 
cognitive development between children up to 5 
years of age exposed to methadone in utero and 
control groups matched for age, race, and 
socioeconomic status, although scores were often 
lower in both groups compared with population data 
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-
Opioid-Use-Disorder-in-Pregnancy
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Stable Cradle
 Started in 1997 at height of the Crack Cocaine 
epidemic.
 A partnership with OSU Wexner Medical Center, 
STEPP Clinic and Maryhaven’s Women’s Program.
 Program supports the STEPP Clinic with “one-on-
one” inpatient  treatment program with an 
addiction specialist and three mentors.
 The Stable Cradle program works as a continuum 
of care to maintain contact and support with each 
pregnant  women  with substance disorders during 
pregnancy and beyond. 
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STABLE CRADLE AGREEMENT REVIEW
STABLE CRADLE FACILITATES  AOD AND PARENTING GROUPS  AT BOTH MARYHAVEN  AND OSUWMC’S STEPP CLINIC 
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STABLE CRADLE 
AGREEMENT 
REVIEW
YES
*IDENTIFIES NEEDS
*REFERRAL REVIEW WITH BASIC 
NEEDS AND OSUWMC STEPP WITH 
MAT
*CURRENT SYSTEM 
INVOLVMENT(COURTS, PROBATION 
OR PAROLE)
*RELEASES OF INFORMATION
*REQUIRED TREATMENT TYPE
*
NO
REFERRALS ARE 
OFFERED 
INFORMATION ON 
COMMUNITY 
SERIVICES 
TREATMENT TYPE/CASE MANAGEMENT
INPATIENT TREATMENT
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INPATIENT 
TREATMENT/CASE 
MANAGEMENT
CLIENT WITH NON 
OPIATESUBUSTANCE 
USE DISORDER 
IDENTIFICATION, 
SOCIAL SEURITY CARE,  
MEDICAL RECORDS
BI-WEEKLY CONTACT 
BY MENTOR AND 
PRENATAL VISITS
ASSIGNMENT OF A 
MENTOR
REFERRAL TO 
OSUWMC FOR 
PRENATAL AND MAT
CONSISTENT 
COMMUNICATION 
POSTPARTUM 
FOLLOW-UP MONTHLY 
AND CONTACT WITH 
MENTORS 
TREATMENT TYPE/CASE MANAGEMENT
INPATIENT TREATMENT WITH OPIATES
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OUTPATIENT 
TREATMENT/CASE 
MANAGEMENT
CLIENT WITH 
OPIATESUBUSTANCE USE 
DISORDER WITH 
PREARRANGED MAT 
SERVICES
IDENTIFICATION, SOCIAL 
SEURITY CARE,  MEDICAL 
RECORDS
BI-WEEKLY CONTACT BY 
MENTOR AND PRENATAL 
VISITS
ASSIGNMENT OF A 
MENTOR
REFERRAL TO OSUWMC 
FOR PRENATAL AND MAT
SERVICES
CONSISTENT 
COMMUNICATION 
POSTPARTUM FOLLOW-
UP MONTHLY AND 
CONTACT WITH 
MENTORS 
OUTPATIENT TREATMENT/CASE MANAGEMENT 
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OUTPATIENT 
TREATMENT/CASE 
MANAGEMENT
DISCUSSION OF 
LOCATIONS 
LINKS CLIENT WITH 
OPIATE SUBUSTANCE USE 
DISORDER TO 
OUTPATIENTS SERVICES
IDENTIFICATION, SOCIAL 
SECURITY CARE,  MEDICAL 
RECORDS, 
TRANSPORTATION AND 
INSURANCE
BI-WEEKLY CONTACT BY 
MENTOR AND PRENATAL 
VISITS
ASSIGNMENT OF A 
MENTOR
REFERRAL TO OSUWMC 
FOR PRENATAL AND MAT 
SERVICES 
CONSISTENT 
COMMUNICATION 
POSTPARTUM FOLLOW-UP 
MONTHLY AND CONTACT 
WITH MENTORS 
Mothers Served by Stable Cradle January, 2016-
December 2017
 A total of 94 pregnant women were served by Stable 
Cradle
 Caucasian Women- 69% (n=65)
 African American Women 23% (n=22)
 Asian American Women 1.06%
 Latina Women-1.06%
 Bi-racial-9.6%
2016-2017 Stable Cradle Annual Report
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Drugs of Choice
 68% reported using opiates
 4.2% used opiates with pills
 9.57% used alcohol with heroin
 3.12% reported  using crack
 1.06% used crystal meth
 4.2% reported using cocaine 
2016-2017 Stable Cradle Annual Report
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Birth Weight and NAS
 Low Birth Weight 8.5% 
 Normal Birth Weight 25.5% 
 Unknown Birth Weight 44.68%
 Neonatal Abstinence Syndrome (NAS) -
17.02 % and without symptoms- 19.4%
2016-2017 Stable Cradle Annual Report
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Stigma and Other Fears 
 Stigma and fear of the child welfare system prevents 
many clients from seeking prenatal care or addiction 
treatment earlier in their pregnancy. 
 Many health care providers and children services 
personnel do not recognize pregnant women with 
opiate disorder have a “disease”. Women report 
feeling disrespected, judged, and stigmatized. 
 Children Services prolongs involvement beyond “the 
issue.” Many clients voiced support for strong 
measures when a woman is not cooperating with 
Children Services 
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Conclusions
 Health care providers will need to consider modifying 
some elements of prenatal care (such as expanded 
STI testing, additional ultrasound examinations for 
fetal growth abnormalities, and in order to meet the 
clinical needs of the patient.
 Continuity of care, including ensuring consistent daily 
dosing of buprenorphine or methadone, is critical to 
success. Pregnant women, with an opioid use 
disorder, opioid agonist pharmacotherapy should 
receive medically supervised withdrawal. 
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Conclusions 
 Early universal screening, brief intervention (such as 
engaging a patient in a short conversation, providing 
feedback and advice), and referral for treatment of 
pregnant women with opioid use and opioid use 
disorder improve maternal and infant outcomes. 
 Contraceptive counseling and access to contraceptive 
services should be a routine part of substance use 
disorder treatment.
 Pregnant women  with opioid use disorder should be 
co-managed by the obstetric care provider and a 
health care provider with addiction medicine 
expertise. 
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-
in-Pregnancy
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Conclusions
 More research is needed to assess the safety 
(particularly regarding maternal relapse), efficacy, and 
long-term outcomes of medically supervised 
withdrawal. 
 Infants born to women who used opioids during 
pregnancy should be monitored by a pediatric care 
provider for neonatal abstinence syndrome. 
 Multidisciplinary long-term follow-up should include 
medical, developmental, and social support. A 
coordinated multidisciplinary approach without 
criminal sanctions has the best chance of helping 
infants and families. 
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